Latest news
Alterity Therapeutics Expands Equity Base With New ASX Share Quotation - TipRanksTipRanks · Mon, 10 Aug 2026 08:22:55 GMTAlterity Therapeutics to Highlight MSA Program at Canaccord Growth Conference - TipRanksTipRanks · Thu, 06 Aug 2026 07:20:58 GMTAlterity Therapeutics Files August 3 Application to Quote ATH Securities - TipRanksTipRanks · Tue, 04 Aug 2026 10:51:34 GMTAlterity Therapeutics Adds 81,838 New Shares to ASX Listing - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 06:58:00 GMTAlterity Therapeutics Secures FDA Pathway and Bolsters Funding for ATH434 Phase 3 in MSA - TipRanksTipRanks · Thu, 30 Jul 2026 07:00:00 GMTAlterity Wins FDA Backing for ATH434 Phase 3 Pathway in Multiple System Atrophy - TipRanksTipRanks · Thu, 30 Jul 2026 01:08:06 GMT